Journal of Personalized Medicine (Jun 2022)

Fetal Doppler Evaluation to Predict NEC Development

  • Miriam Duci,
  • Erich Cosmi,
  • Pierpaolo Zorzato,
  • Ambrogio Pietro Londero,
  • Giovanna Verlato,
  • Eugenio Baraldi,
  • Eugenio Ragazzi,
  • Francesco Fascetti Leon,
  • Silvia Visentin

DOI
https://doi.org/10.3390/jpm12071042
Journal volume & issue
Vol. 12, no. 7
p. 1042

Abstract

Read online

Antenatal factors play a role in NEC pathogenesis. This study aimed to investigate the predictive value of fetal ductus venosus doppler (DV) for NEC in fetal growth restriction fetuses (FGRF) and to assess the predictive accuracy of IG21 and Fenton curves in NEC development. Data from FGRF, postnatal findings, and Doppler characteristics were collected between 2010 and 2020 at a single center. Patients were then divided into two groups (i.e., with and without NEC). Bivariate and multivariate analyses were performed. We identified 24 cases and 30 controls. Absent or reversed end-diastolic flow (AREDF) and increased resistance in the DV were more impaired in cases (p p p < 0.05). The predictive model for NEC (model 4), including Fenton z-score, WBC, PDA, and DV had an AUC of 84%. Fetal Doppler findings proved effective in predicting NEC in FGR. The Fenton z-score was the most predictive factor considering the fetal growth assessment showing high sensitivity.

Keywords